NIH-funded research R01 grant

MOVE Trial: Tailored motivational support to help African Americans stick with dialysis

Official title: MOVE Trial: MOtiVational Strategies to Empower African Americans to Improve Dialysis Adherence

Funded at Vanderbilt University Medical Center · NIH-11416784 · Data updated 2026-11-12

A study tests a customized motivational interviewing approach to help African American dialysis patients stay adherent to their treatment, aiming to reduce hospitalizations and improve health.

More Dialysis research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionVanderbilt University Medical Center
NIH-funded
Lab location1 site (Nashville, United States)
Project startAugust 15, 2022
Project endMay 31, 2027
Funding year2026
Award (this year)$547,195
NIH project number5R01DK133530-05
Project IDNIH-11416784 on NIH RePORTER

Who could benefit from this research

Could help

African American adults on hemodialysis who experience challenges with sticking to their treatment schedule.

Less likely to help

Patients who do not participate in motivational interviewing or whose barriers are not addressed by the program may not experience benefit.

What this research studies

This project focuses on improving adherence to hemodialysis among African American patients with kidney failure. It tests a tailored motivational interviewing program designed to strengthen motivation and the patient–provider relationship, using a rigorous theoretical framework to guide the intervention. The researchers will compare the tailored approach to standard care to see if it improves dialysis adherence and related health outcomes. The goal is to develop scalable strategies that can be used in real clinics to improve kidney disease care for African American communities.

Why it matters

Potential benefit: If successful, patients could experience fewer hospitalizations and better overall kidney health thanks to improved adherence.

How similar studies have gone: Previous motivational interviewing work shows promise in improving adherence, but tailored approaches for African Americans with ESKD are limited and require further testing.

Where this research is happening

  • Vanderbilt University Medical Center
    Nashville, United States
    Active

Researchers

  • Principal investigator: Umeukeje, Ebele M — Vanderbilt University Medical Center
  • Study coordinator: Umeukeje, Ebele M

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.